A clinical trial’s encouraging results won US Food and Drug Administration breakthrough therapy status for an LSD formulation to treat generalized anxiety disorder, Mind Medicine Inc. announced ...

The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy status to an LSD formula to treat generalized anxiety disorder after an initial study has shown that a single dose of the ...

LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in the U.S. for ...

The following interview is with Dr. Matt Oram, the author of The Trials of Psychedelic Therapy: LSD Psychotherapy in America. It has been edited for clarity and brevity. Richert: There’s a lot of ...

Doctors in Sacramento are using transcranial magnetic stimulation and experimental drugs inspired by psychedelics to address ...

There’s growing buzz around the use of psychedelics to treat health conditions like depression, anxiety, post-traumatic stress disorder (PTSD), and addiction. Given the expanding catalog of ...

MindMed Inc. said Tuesday it’s on track to launch Phase 3 clinical trials with up to 440 people starting later this year for its treatment of generalized anxiety disorder (GAD) through use of ...

LSD usage is on the rise among U.S. adults – especially young adults with depression. And the trend mirrors growing research into the psychedelic drug's ability to treat mental health disorders like ...

“While prior research has documented the benefits of combining LSD with psychotherapy to alleviate anxiety associated with life-threatening conditions, this groundbreaking study is the first to show ...